Canopy Growth Corp. (CGC)
0.5612
-0.01
(-2.20%)
USD |
NASDAQ |
Nov 13, 16:00
0.556
-0.01
(-0.93%)
Pre-Market: 08:05
Canopy Growth EPS Diluted (Quarterly) : -0.0687 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -0.0687 |
| June 30, 2026 | -0.0249 |
| March 31, 2026 | -0.293 |
| December 31, 2025 | -0.13 |
| September 30, 2025 | -0.0132 |
| June 30, 2025 | -0.172 |
| March 31, 2025 | -0.8837 |
| December 31, 2024 | -0.7902 |
| September 30, 2024 | -1.083 |
| June 30, 2024 | -1.173 |
| March 31, 2024 | -0.765 |
| December 31, 2023 | -1.920 |
| September 30, 2023 | -3.227 |
| June 30, 2023 | -0.5155 |
| March 31, 2023 | -9.488 |
| December 31, 2022 | -39.31 |
| September 30, 2022 | -4.744 |
| June 30, 2022 | -41.04 |
| March 31, 2022 | -11.66 |
| December 31, 2021 | -2.194 |
| September 30, 2021 | -0.2232 |
| June 30, 2021 | 7.894 |
| March 31, 2021 | -14.60 |
| December 31, 2020 | -18.61 |
| September 30, 2020 | -0.6474 |
| Date | Value |
|---|---|
| June 30, 2020 | -2.151 |
| March 31, 2020 | -27.69 |
| December 31, 2019 | -1.986 |
| September 30, 2019 | -8.160 |
| June 30, 2019 | -4.006 |
| March 31, 2019 | -7.341 |
| December 31, 2018 | 1.620 |
| September 30, 2018 | -11.63 |
| June 30, 2018 | -3.098 |
| March 31, 2018 | -2.475 |
| December 31, 2017 | 0.064 |
| September 30, 2017 | -0.0638 |
| June 30, 2017 | -0.4464 |
| March 31, 2017 | -1.058 |
| December 31, 2016 | 0.1499 |
| September 30, 2016 | 0.3833 |
| June 30, 2016 | -0.3103 |
| March 31, 2016 | -0.364 |
| December 31, 2015 | -0.2996 |
| September 30, 2015 | 0.3824 |
| June 30, 2015 | 0.1625 |
| March 31, 2015 | -0.2417 |
| December 31, 2014 | -0.6164 |
| September 30, 2014 | -0.5515 |
| June 30, 2014 | -0.275 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| CannaPharmaRx, Inc. | -0.0028 |
| Tilray Brands, Inc. | -0.3235 |
| Hero Technologies, Inc. | -- |
| WEED, Inc. | -0.0007 |
| THC BioMed International Ltd. | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -29.07M |
| Revenue (Quarterly) | 58.13M |
| Total Expenses (Quarterly) | 87.19M |
| Enterprise Value | 207.23M |
| Gross Profit Margin (Quarterly) | 21.09% |
| Profit Margin (Quarterly) | -50.01% |
| Earnings Yield | -92.05% |
| Normalized Earnings Yield | -52.01 |